Hideki Takeuchi

779 total citations
37 papers, 403 citations indexed

About

Hideki Takeuchi is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Hideki Takeuchi has authored 37 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Cancer Research. Recurrent topics in Hideki Takeuchi's work include Breast Cancer Treatment Studies (11 papers), Ultrasound Imaging and Elastography (7 papers) and Photoacoustic and Ultrasonic Imaging (7 papers). Hideki Takeuchi is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Ultrasound Imaging and Elastography (7 papers) and Photoacoustic and Ultrasonic Imaging (7 papers). Hideki Takeuchi collaborates with scholars based in Japan, Hungary and United Kingdom. Hideki Takeuchi's co-authors include Toshiaki Saeki, Takashi Shigekawa, Akihiko Osaki, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane, Hiroshi Sano, Takashi Azuma, Hiroko Shimada and Shu Takagi and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Japanese Journal of Applied Physics.

In The Last Decade

Hideki Takeuchi

36 papers receiving 396 citations

Peers

Hideki Takeuchi
Mariël Brinkhuis Netherlands
Brandon Cooper United States
Serene S. Foo Australia
Rakesh Bam United States
Mariël Brinkhuis Netherlands
Hideki Takeuchi
Citations per year, relative to Hideki Takeuchi Hideki Takeuchi (= 1×) peers Mariël Brinkhuis

Countries citing papers authored by Hideki Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Hideki Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Takeuchi more than expected).

Fields of papers citing papers by Hideki Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Takeuchi. The network helps show where Hideki Takeuchi may publish in the future.

Co-authorship network of co-authors of Hideki Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Takeuchi. A scholar is included among the top collaborators of Hideki Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Takeuchi. Hideki Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Shinya, Takashi Chishima, Hideki Takeuchi, et al.. (2022). Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast Cancer. In Vivo. 36(2). 859–864. 1 indexed citations
2.
Yamada, Akimitsu, Masanori Oshi, Hideki Takeuchi, et al.. (2022). A case of matrix-producing carcinoma of the breast treated with preoperative chemotherapy. Gland Surgery. 11(8). 1424–1430. 1 indexed citations
3.
Yamamoto, Shinya, Takashi Chishima, Hideki Takeuchi, et al.. (2021). Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer. In Vivo. 35(4). 2439–2444. 4 indexed citations
4.
Ueda, Shigeto, Takashi Sakurai, Takashi Shigekawa, et al.. (2017). Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety. International Journal of Clinical Oncology. 22(5). 880–886. 8 indexed citations
5.
Qu, Xiaolei, Takashi Azuma, Hideki Takeuchi, et al.. (2017). Limb muscle sound speed estimation by ultrasound computed tomography excluding receivers in bone shadow. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 10139. 101391B–101391B. 5 indexed citations
6.
Ueda, Shigeto, Toshiaki Saeki, Hideki Takeuchi, et al.. (2016). In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab. British Journal of Cancer. 114(11). 1212–1218. 78 indexed citations
7.
Ueda, Shigeto, Takashi Shigekawa, Hideki Takeuchi, et al.. (2016). Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT. Journal of Nuclear Medicine. 57(8). 1189–1195. 16 indexed citations
8.
Shigekawa, Takashi, Akihiko Osaki, Hiroshi Sekine, et al.. (2015). Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study. BMC Cancer. 15(1). 253–253. 4 indexed citations
9.
Ueda, Shigeto, Ichiei Kuji, Takashi Shigekawa, et al.. (2014). Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients. PLoS ONE. 9(6). e98715–e98715. 19 indexed citations
10.
Ueda, Shigeto, Takashi Shigekawa, Hideki Takeuchi, et al.. (2014). Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy. Cancer Science. 105(7). 833–839. 11 indexed citations
11.
Shigekawa, Takashi, et al.. (2013). [Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report].. PubMed. 40(2). 225–7. 3 indexed citations
12.
13.
Shigekawa, Takashi, Hideki Takeuchi, Michiko Sugiyama, et al.. (2012). Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy. The American Journal of Surgery. 204(4). 487–493. 15 indexed citations
14.
Chu, Jan‐Show, et al.. (2012). The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities. Cell Cycle. 11(5). 934–952. 12 indexed citations
15.
Takeuchi, Hideki, Kiyoshi Yoshinaka, Akira Sasaki, et al.. (2011). 3J5-3 Real Time HIFU Beam Imaging(Medical Ultrasound). 32. 583–584. 4 indexed citations
16.
Ueda, Shigeto, Toshiaki Saeki, Takashi Shigekawa, et al.. (2011). 18F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response. International Journal of Clinical Oncology. 17(3). 276–282. 23 indexed citations
17.
Takeuchi, Hideki, Toshiaki Saeki, Takashi Shigekawa, et al.. (2010). BiClamp forceps significantly shorten the operation time for breast surgery. Surgery Today. 40(8). 706–710. 5 indexed citations
18.
Nishimura, Reiki, Takeshi Tominaga, Morihiko Kimura, et al.. (2008). Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial. Anti-Cancer Drugs. 19(9). 911–915. 2 indexed citations
19.
Ueda, Shigeto, Hitoshi Tsuda, Kazuhiko Sato, et al.. (2006). Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin‐like growth factor receptor type 1. Cancer Science. 97(7). 597–604. 34 indexed citations
20.
Kamiyoshi, Michiharu, Hideki Takeuchi, & Katuhide TANAKA. (1978). Progesterone and Estradiol-17β Concentrations in Plasma of Hens following Injection of LH. Nihon Chikusan Gakkaiho. 49(4). 301–303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026